Elon Musk’s Neuralink gets green light for human clinical trials

Elon Musk’s company Neuralink last week announced that it received FDA approval to begin the first human clinical trials of its experimental brain implant device, which the company said was “an important first step that will one day allow our technology to help many people.”

The executive’s field guide to disruptive innovation

What is Neuralink?

Neuralink, which was founded in 2016, is a neurotech company that works with brain-computer interface (BCI) technology. This technology uses electronic implants to decode brain activity and transmit it to computers. According to the Washington Post, researchers hope to use BCI to restore function in people...